CoinInsight360.com logo CoinInsight360.com logo
America's Social Casino

CoinTelegraph 2025-05-23 22:19:07

Semler Scientific boosts BTC holdings with $50M purchase

Semler Scientific, a medical device company, purchased of $50 million worth of Bitcoin between May 13 and May 22, bringing the market value of the company’s Bitcoin ( BTC ) holdings to $474.4 million, keeping it within the top 13 of BTC Treasury companies. According to a May 23 disclosure, Semler bought a total of 455 BTC for an average purchase price of $109,801. To buy the Bitcoin, Semler Scientific used proceeds from an at-the-market stock offering program. So far, the company has sold roughly 3 million shares of common stock for net proceeds of $115 million. Semler Scientific’s shares have fallen 1.36% on the same day as the disclosure, though the decrease in its share price is largely in line with the Nasdaq’s performance. That index, which follows top tech stocks, is down 1% on the day. Semler Scientific share price. Source: Google Finance In its Q1 2025 earnings report released on May 13, the company revealed a 44% drop in revenue year-over-year . Despite the claimed success of its Bitcoin treasury plan, Semler Scientific’s shares have dropped 18% in 2025, according to Google Finance. Bitcoin treasury companies, or companies that traditionally sell equity or issue debt to buy BTC, had been drawing the interest of investors looking for exposure to Bitcoin price fluctuations. Michael Saylor's Strategy debuted its BTC reserve in August 2020, when it started purchasing Bitcoin. Bitcoin is up 181.6% year to date, while Semler Scientific shares rose 53% since announcing the BTC approach in May 2024. Magazine: ZK-proofs are bringing smart contracts to Bitcoin — BitcoinOS and Starknet

Read the Disclaimer : All content provided herein our website, hyperlinked sites, associated applications, forums, blogs, social media accounts and other platforms (“Site”) is for your general information only, procured from third party sources. We make no warranties of any kind in relation to our content, including but not limited to accuracy and updatedness. No part of the content that we provide constitutes financial advice, legal advice or any other form of advice meant for your specific reliance for any purpose. Any use or reliance on our content is solely at your own risk and discretion. You should conduct your own research, review, analyse and verify our content before relying on them. Trading is a highly risky activity that can lead to major losses, please therefore consult your financial advisor before making any decision. No content on our Site is meant to be a solicitation or offer.